Dr. Reddy’s 1000 crore investment: One of the leading Pharmaceutical companies in the country, Dr. Reddy’s Laboratories’ 1000 crore investment, Hyderabad, has allocated about Rs 1,000 crore as investment expenditure for the current financial year (2021-22). However, the cost of the funding will depend on the conditions in the corona, said the company’s CEO Erez Israeli. Reddy’s had invested about Rs 1,000 crore in the last financial year (2020-21). Against this background will the investment cost of the company for this financial year be higher as compared to the past? Israel responded to an analyst’s question as follows.
Hope for the future.
Dr. Reddy expressed optimism about the future in light of the impact of Kovid-19 on domestic and foreign markets. In fact, despite the uncertainty over the current business situation, Israeli has expressed confidence that it will be able to sustain its multi-pronged growth path.
These are the goals.
Organic business development, fundraising, product growth, strong marketing, digitalization, and expansion are the goals of the organization, said CEO Israeli. It was clarified that non-organic business development will be given a big boost to achieve long-term growth. The company had a net surplus of Rs 751 crore at the end of March this year. Revenue for 2020-21 was Rs 18,972 crore.
Telangana Corona Emergency Contact Information:
For Free Ambulance (Cyberabad)
For Free cab Services (Rachakonda)